![OncoCyte Corporation logo](/logos/OCX.webp)
OncoCyte Corporation
NASDAQ:OCX
Overview | Financials
Company Name | OncoCyte Corporation |
Symbol | OCX |
Currency | USD |
Price | 3.19 |
Market Cap | 42,645,196 |
Dividend Yield | 0% |
52-week-range | 2.08 - 4.34 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joshua Riggs |
Website | https://oncocyte.com |
An error occurred while fetching data.
About OncoCyte Corporation
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD